Skip to content

Janssen Pharmaceuticals Inc. v. A.Y.

Petition for certiorari denied on May 17, 2021

Docket No. Op. Below Argument Opinion Vote Author Term
20-1069 Pa. Super. Ct. N/A N/A N/A N/A OT 2020

Issue: Whether federal law preempts state-law claims that a manufacturer failed to provide adequate warnings relating to the off-label use of their products, where federal law bars the manufacturer from unilaterally altering its labeling to provide such warnings.

DateProceedings and Orders (key to color coding)
01/29/2021Petition for a writ of certiorari filed. (Response due March 8, 2021)
02/11/2021Motion to extend the time to file a response from March 8, 2021 to April 7, 2021, submitted to The Clerk.
02/12/2021Motion to extend the time to file a response is granted and the time is extended to and including April 7, 2021.
03/04/2021Brief amicus curiae of Product Liability Advisory Council, Inc. filed.
03/05/2021Brief amicus curiae of Washington Legal Foundation filed.
03/08/2021Brief amici curiae of Pharmaceutical Research and Manufacturers of America, Chamber of Commerce of the United States of America, and American Tort Reform Association filed.
03/08/2021Brief amici curiae of National Association of Manufacturers and International Association of Defense Counsel filed.
04/07/2021Brief of respondents A.Y. and Billy Ann Yount in opposition filed.
04/21/2021DISTRIBUTED for Conference of 5/13/2021.
04/21/2021Reply of petitioners Janssen Pharmaceuticals, Inc., et al. filed. (Distributed)
05/17/2021Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.